Clinical Trial Update: Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patients [NA]

View source ↗

Summary

A completed clinical trial evaluating an additional GLP-1 analogue for patients with poorly controlled type 2 diabetes on continuous subcutaneous insulin infusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 analogue (unspecified) (GLP-1 analogue)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED